• Subscribe
  • About us
  • Advertise with us

NeuroSens

Menu

Skip to content
  • Home
  • Neurology
  • Psychiatry

Topic: SCHIZOPHRENIA

First-episode schizophrenia: two reports from the EUFEST study

May 8, 2013  

Preventing relapses in schizophrenia: meta-analysis

February 13, 2013  

Preventing relapses in schizophrenia: meta-analysis

January 9, 2013  

The woes of neurology drug development: Eli Lilly

November 21, 2012  

Image broadcasting: teleconferencing useful in schizophrenia

June 8, 2011  

Metabolic effects of second-generation antipsychotics: meta-analysis

June 8, 2011  

Pilot study of adjunctive L-lysine in schizophrenia

June 8, 2011  

Positive symptoms common in non-converters to psychosis

May 25, 2011  

5 patterns of antipsychotic drug response reported

May 25, 2011  

Delay in hospitalization with clozapine

May 25, 2011  
1
2
3

Browse by Topic

  • MS (442)
  • EAN 2026 (2)
  • CLINICAL CASES (21)
  • AAN 2026 (3)
  • ACTRIMS Forum 2026 (4)
  • EPILEPSY (38)
  • AES 2025 (1)
  • BIOMARKERS IN MS (61)
  • ECTRIMS 2025 (7)
  • Library (18)
  • EAN 2025 (2)
  • AAN 2025 (5)
  • ACTRIMS 2025 (6)
  • AES 2024 (1)
  • ECTRIMS 2024 (6)
  • EAN 2024 (3)
  • AD (85)
  • AAN 2024 (5)
  • ACTRIMS Forum 2024 (2)
  • PD (77)
  • COVID-19 (58)
  • MIGRAINE (25)
  • DEPRESSION (36)
  • STROKE (22)
  • SCHIZOPHRENIA (25)
  • DEMENTIA (10)
  • SLEEP (2)
  • PAIN (3)
  • BPD (4)
  • ALS (1)

Popular Posts

  • Proton pump inhibitors linked to neurological conditions posted on November 29, 2019
  • Management of refractory epilepsy: highlights from ILAE 2025 posted on October 29, 2025
  • Revised recommendations on the differential diagnosis of MS posted on July 25, 2023
Copyright 2026 Lind Publishing Inc All rights reserved. Developed by Integration New Media, INC. (INM)
Contact Us Terms and Conditions